Evidence map›Paper›PMID 34338154›Full record

ArticleCell adhesion & migration2021

Role of tight junction-associated MARVEL protein marvelD3 in migration and epithelial-mesenchymal transition of hepatocellular carcinoma.

Yanmeng Li, Teng Li, Donghu Zhou, Jia Wei, Zhenkun Li, Xiaojin Li, Siyu Jia, Qin Ouyang, Saiping Qi, Zhibin Chen and 5 more

Open access · goldAbstract read
In one paragraph

Article in Cell adhesion & migration, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 20 citations in OpenAlex.

  1. Increased expression of Ribonucleic acid export 1 (Journal of gastrointestinal oncology · 2026
    Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. High expression ofFrontiers in genetics · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Yanmeng LiExperimental Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Teng LiDepartment of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
Donghu ZhouExperimental Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Jia WeiDepartment of Oncology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Zhenkun LiExperimental Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Xiaojin LiExperimental Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Siyu JiaExperimental Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Qin OuyangExperimental Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Saiping QiExperimental Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Zhibin ChenExperimental Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Bei ZhangExperimental Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Jing YuDepartment of Oncology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Jidong JiaLiver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Anjian XuExperimental Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Jian HuangExperimental Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Capital Medical University · CNBeijing Friendship Hospital · CNNational Clinical Research Center for Digestive Diseases · CNChinese Academy of Medical Sciences & Peking Union Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MarvelD3, a recently identified tight junction membrane protein, could be associated with hepatocellular carcinoma (HCC). We aimed to investigate the role of marvelD3 in Epithelial-Mesenchymal Transition (EMT) and migration of HCC and explore the underlying molecular mechanisms. First, we assessed marvlD3 expression in HCC and normal liver tissues and found loss of marvelD3 expression was significantly correlated with the occurrence and TNM stage of HCC. Second, we detected that marvelD3 was downregulated in HCC cells with transforming growth factor β1 and snail/slug-induced EMT. Finally, we analyzed expression of marvelD3 protein was significantly associated with EMT and the NF-κB signaling pathway. Our study demonstrated that MarvelD3 inhibited EMT and migration of HCC cells along with inhibiting NF-κB signaling pathway.

Indexed as

Carcinoma, HepatocellularLiver NeoplasmsCell Line, TumorEpithelial-Mesenchymal TransitionHumansTight Junction ProteinsTight JunctionsTight Junction ProteinsEMTHepatocellular carcinomamarvelD3migrationNF-κB

Identifiers

PMID34338154
PMCPMC8331009
OpenAlexW3135666237

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.